The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial

Author:

Miyazaki Taiga,Nakamura Shigeki,Hashiguchi Kohji,Kobayashi Tsutomu,Fukushima Kiyoyasu,Fukuda Yuichi,Kondo Akira,Inoue Yuichi,Koga Hironobu,Sasaki Eisuke,Nagayoshi Yosuke,Higashiyama Yasuhito,Yoshida Masataka,Takazono Takahiro,Saijo Tomomi,Morinaga Yoshitomo,Yamamoto Kazuko,Imamura Yoshifumi,Mikushi Shinya,Izumikawa KoichiORCID,Yanagihara Katsunori,Kohno Shigeru,Mukae Hiroshi

Funder

Daiichi Sankyo Co., Ltd

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference29 articles.

1. Trends in leading causes of death,2017

2. Bacterial pneumonia in elderly Japanese populations;Miyashita;Jpn Clin Med,2018

3. The JRS guidelines for the management of pneumonia in adults (in Japanese),2017

4. In vitro and in vivo antibacterial activity of sitafloxacin (in Japanese);Kanda;Jpn J Chemother,2008

5. Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001);Jones;Diagn Microbiol Infect Dis,2003

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3